OpenAI acquires Orchestra Bio

What happened

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Why it matters

The transaction could alter ownership, competitive positioning and capital allocation around OpenAI.

Affected entities

View evidence

2 reports · 1 original report · 2 independent

1. OpenAIPrimary source · Supports · EN · 100%
   OpenAI acquires Orchestra Bio ↗Oct 19, 2026, 8:00 PM
2. TechCrunch AIIndependent · Supports · EN · 67%
   OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business ↗Oct 20, 2026, 4:35 PM

Claims

• OpenAI acquires Orchestra Bio Observed

Conflicts

No material conflict detected in the available evidence.

Timeline

1. October 19, 2026 at 8:00 PMFirst reported
2. Oct 20, 2026, 4:35 PMPrimary source · 68/82%

Market move following event

Market reaction is not yet available for this asset and time window.

Score explanation